You are here: All Products  > Abbisko Out-Licenses Rights to Non-Oncology Indications for CSF-1R Inhibitor

Abbisko Out-Licenses Rights to Non-Oncology Indications for CSF-1R Inhibitor

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products